María U. Moreno

Medicine · Health Sciences

28h-index3.4kcitations75works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nitric Oxide and Endothelin Effects(18), Neutrophil, Myeloperoxidase and Oxidative Mechanisms(18), Cardiac Fibrosis and Remodeling(10), Eicosanoids and Hypertension Pharmacology(8), Atherosclerosis and Cardiovascular Diseases(8)

Publications75 total

Defining FDA Approved Treatments as Reasonable and Necessary: Perspectives of Individuals Living with Alzheimer's Disease and Care Partners
The Journal of Prevention of Alzheimer s Disease·2023Open Access
Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides
JACC Heart Failure·2022· 18 cited
Oxidative Stress in Cardiovascular Disease and Comorbidities
Antioxidants·2022· 7 citedOpen Access
Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the <scp>HOMAGE</scp> clinical trial
European Journal of Heart Failure·2021· 25 citedOpen Access
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
Nature Reviews Cardiology·2021· 316 cited
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action
Nefrología (English Edition)·2020· 8 citedOpen Access
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action
Nefrología·2019· 32 citedOpen Access
Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh‐density mapping study
Journal of Cardiovascular Electrophysiology·2019· 13 cited
Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation
Journal of the American College of Cardiology·2019· 65 cited
Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease
Hypertension·2019· 57 citedOpen Access
CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation
Hypertension·2019· 107 citedOpen Access
The renal immune-inflammatory component of arterial hypertension: emerging therapeutic strategies
Cardiovascular Research·2018· 4 citedOpen Access
Myocardial Remodeling in Hypertension
Hypertension·2018· 204 citedOpen Access
Hypertensive Heart Disease
Elsevier eBooks·2017· 6 cited
Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men
Free Radical Research·2017· 19 cited
Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites
Scientific Reports·2017· 34 citedOpen Access
Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome
Journal of Hypertension·2017· 75 cited
The Hypertensive Myocardium
Medical Clinics of North America·2016· 30 cited
Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients
Clinical Science·2016· 13 citedOpen Access
Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure
Journal of the American College of Cardiology·2016· 157 cited
page 1 of 4Next →

Frequent Co-authors

Javier Dı́ez(40), Gorka San José(31), Guillermo Zalba(26), Ana Fortuño(21), Arantxa González(21), Begoña López(20), Susana Ravassa(17), Óscar Beloqui(15), Javier Beaumont(14), Ramón Querejeta(8), Anna F. Dominiczak(5), Christian Delles(4), Jane A. Dymott(3), Ana Baltanás(3), Manuel F. Landecho(3), José L. Miguel‐Carrasco(3), Nuria Garcı́a-Fernández(3), Antoni Bayés‐Genís(2), Kattalin Echegaray(2), Chiara Taurino(2)